We report that, in rats, the lethal consequences of high-dose endotoxin challenge are exacerbated by the intravascular administration of prostaglandin E1 but attenuated by the intravascular administration of endocytosable particles. This protection is mediated by opsonins. Nonopsonizable particles were unable to provide protection unless first pseudoopsonized with antibody directed against the CR3 (CD11b/CD18) phagocyte receptor. We show that endogenously opsonized particles can act in concert with prostaglandin El (putatively by elevation of neutrophil intracellular cAMP and the resultant downregulation of CR3) to completely rescue animals from the lethal late-stage sequelae of experimental endotoxemia. These data illustrate that the interaction of particles with cellular receptors can transform the overall systemic response to prostaglandin E1 from pro-to antiinflammatory. This suggests a role for multiple receptor engagement events in defining the systemic prostaglandin response and offers a rationale for developing new therapeutic modalities in the treatment of sepsis and other inflammatory diseases.
completely rescue animals from the lethal late-stage sequelae of experimental endotoxemia. These data illustrate that the interaction of particles with cellular receptors can transform the overall systemic response to prostaglandin E1 from pro-to antiinflammatory. This suggests a role for multiple receptor engagement events in defining the systemic prostaglandin response and offers a rationale for developing new therapeutic modalities in the treatment of sepsis and other inflammatory diseases.
Opinion concerning the role of prostaglandins in the inflammatory cascade is divided. Proinflammatory prostaglandin activities such as vasodilation and hyperalgesia have been utilized to explain the mechanism by which nonsteroidal antiinflammatory drugs exert their effects (1) (2) (3) . In contrast, the release of inflammatory mediators from leukocyte lysosomes is reduced by prostaglandin E1 (PGE1) through elevation of intracellular adenosine cyclic-3',5'-monophosphate (cAMP) (4) (5) (6) and the subsequent inhibition of degranulation. This PGE1-mediated elevation of cAMP is augmented by leukocyte phagocytosis of both digestible opsonized sheep erythrocytes (5) as well as undigestible particles-e.g., zymosan (6) . PGE1 can inhibit the chemotaxis and adhesion of neutrophils to endothelial cells both in vitro and in vivo (7) . Since neutrophil extravasation with release of inflammatory mediators is critical in the development of systemic inflammatory disease, these findings have suggested new paradigms for the development of rational therapies, but clinically relevant studies have not been accomplished (8) (9) (10) (11) (12) (13) (14) 
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half-time of < 2 min. Alternatively, liposomes were made as above without the inclusion of PGEI. The possibility that endotoxin adsorbed to the liposomes and was therefore inactivated was ruled out. Liposomes were incubated with endotoxin at a ratio of 1.6 x 1012 liposome particles to 25 mg of endotoxin for -4 hr. After this incubation the endotoxin binding to the liposomes was determined with a Limulus amoebocyte lysate assay (Endosafe, Charleston, SC). No liposome-associated endotoxin was detected. Fluorescent liposomes were made as above except that the fluorescent lipophilic label 1,1 '-dioctadecyl-3,3,3 ',3 '-tetramethylindocarbocyanine perchlorate (dil; Molecular Probes) was included at 0.5 mol 6c.
cAMP Assays. Human neutrophils ( 107 cells per ml in RPMI 1640 with 10% human AB serum) were either assayed directly for cAMP or stimulated for 15 min at 37°C with either PGE, (10 gM), liposomes (3 x 10'( per ml), or PGE1 plus liposomes.
The reactions were terminated by addition of ice-cold ethanol (final concentration, 65% by volume). The samples were allowed to settle for 1 hr at -20°C and the cAMP-containing supernatants were recovered and centrifuged at 2000 x g for 15 min at 4°C. The remaining supernatants were evaporated under nitrogen and assayed with a commercial kit (Amersham).
Flow Cytometry. Determinations were made with a Profile I flow cytometer (Coulter) equipped with an argon ion laser emitting 15 Cowan I strain (19) ; Calbiochem] was pelleted and the cells were suspended in 100 ,ul of phosphate-buffered saline containing either 200 jig of antibody or 20 ,ul of heat-inactivated rat serum (final IgG concentration, 2-4 mg/ml). After incubation for 1 hr at room temperature with constant shaking, the cells were washed twice and suspended in 1 ml of 0.2 M sodium borate (pH 9.0). The antibodies were coupled to the particles by the addition of dimethylpimelimidate (20 mM (4) (5) (6) and the direct effect of PGE, itself on preventing neutrophil adhesion to capillary endothelium (7), we were led to investigate whether large unilamellar liposome vesicles-i.e., biodegradable 100-nm egg phosphatidylcholine particles plus PGE1-might be effective in reducing mortality in lethal models of experimental endotoxemia. In serum, such vesicles adsorb fibrinogen and fibronectin and fix C3bi and are thus endocytosed as a consequence of engagement of the phagocytic receptor CR3 (CDllb/CD18) (20) . In initial in vitro experiments we found that liposomes labeled with 0.5 mol % nonexchangeable fluorescent lipophilic probe diI (21) targeted to human neutrophils and monocytes but not lymphocytes in whole blood when these cells were exposed to endotoxin (Fig. 1) 
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Control LPS Lymphocytes   FIG. 1 . One-hundred-nanometer liposomes target to endotoxin-stimulated phagocytes in whole blood. Whole human blood, collected as described, was incuhated with fluorescent dil-labeled 100-nm liposomes in the presence or absence of endotoxin (LPS at I jig/ml) at 37°C with constant rocking. After a 30)-min incubation, the blood was supplemented with disodium EDTA (10 mM) and analyzed by flow cytometry. receptors (data not shown). Human neutrophil cAMP levels were increased by either PGE1 or liposomes and were cooperatively increased by liposomes plus PGE1 (Table 1) , presumably through concomitant engagement of CR3 and EP2 receptors. In our hands this cooperative increase in cAMP was accompanied by a decrease in the expression of neutrophil CD18 (Fig. 2) , a likely consequence of the inhibition of Ca2> signaling transients (22) and subsequent inhibition of mitogenactivated protein kinase (23, 24) and other Ca2+-dependent protein kinases (25) . Since the interaction of CD18 with endothelial intercellular adhesion molecule 1 permits neutrophil extravasation from the vasculature into tissue and thus mediates the systemic inflammatory response, these data suggested that PGE1 and liposomes might attenuate this response in vivo.
Liposomes Divert the Systemic Response to PGE1 from Proto Antiinflammatory. Our initial in vivo experiments were designed to assess the efficacy of PGE1 and liposomes in rat models of endotoxemia. The results (Fig. 3) indicate that when administered alone, PGE1 was proinflammatory; it increased both the rate and the extent of endotoxin-induced mortality. In contrast, liposomes reduced mortality. Remarkably, PGE1 administered in combination with liposomes became antiinflammatory and afforded complete protection against endotoxin-induced death. These data mirrored those describing the effect of opsonized particles on the downregulation of CD18 expression (Fig. 2) for particles in permitting a systemic antiinflammatory response to PGE1. In the absence of particles, neutrophil receptor engagement and intracellular signaling were most likely diminished, allowing the inflammatory activities of PGE1 to predominate.
Liposomes Influence the Systemic Antiinflammatory Response to PGE1 in a Dose-Dependent Fashion. As mentioned, the increased survival obtained by administering liposomes indicated an important role for particles in the outcome of the PGE1/liposome treatment modality and suggested a therapeutic particle effect. Accordingly, we assessed survival by treating animals with a constant dose of PGE1 but increased the particle number (Fig. 4) . Increasing the particle number resulted in increased survival. The maximal response was obtained with .1.2 x 1012 particles per kg. Virtually identical responses were obtained with both liposomes and 100-nm latex microspheres. We next assessed survival after treating with increasing doses of PGE1 either in the absence or presence of Systemic antiinflammatory activity of PGE1 is particle dependent. At time 0, rats were injected intravenously with LPS (50 mg/kg). Particles as either 100-nm liposomes (black bars) or 100-nm latex microspheres plus PGE1 (40 ,ug/kg) (gray bars) were intravenously injected simultaneously with PGE1 (40 ,tg/kg) at the indicated particle number. Survival was assessed at 24 hr. Saline and endotoxin controls are not shown; survival for these groups was 100% and 50%, respectively. For each group, n = 16. Liposomes and latex microspheres were assessed for endotoxin adsorption by Limulus amoebocyte lysate assay. There was no detectable sequestration of endotoxin.
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1.6 X 1012 particles per kg. Increasing the dosage of PGE1 in the absence of particles resulted in a dose-dependent increase in mortality (Fig. 5) . However, increasing the PGE1 dose in the presence of particles resulted in a dose-dependent increase in survival. As both liposomes and nonmetabolizable latex microspheres afforded similar responses, we can rule out an effect inherent to organized assemblies of lipids or to other components of liposome systems.
Inherent Protection of Particles in Endotoxemia Is Mediated by Engagement of the CR3 Receptor. To evaluate whether particle interaction with CR3 was obligate for the protective effect observed, we utilized particles which are not endogenously opsonized. In these experiments Pansorbin particles (hardened S. aureus cells coated with protein A) incubated in heat-denatured rat serum, and thus nonopsonizable and nonendocytosable, were not protective (Table 2) . However, when these particles were first pseudoopsonized by conjugation with antibodies to the CR3 (CD18/CD11b) phagocyte receptor, a procedure known to refresh interaction of the particles with CR3 (26), the protective effect was also refreshed. Neither anti-CR3 alone nor Pansorbin conjugated with antibodies directed against either major histocompatibility class I antigen or IgGl was protective (data not shown). These data show that the systemic activity of PGE1 can be changed from inflammatory to antiinflammatory by particle-directed engagement of CR3. Whether the protective effect obtained by pseudoopsonization of Pansorbin is mediated by cAMP and the resultant antiinflammatory signaling cascade remains speculative. Im- (26) , but the effect on cAMP has not been defined (27, 28) .
Endogenously Opsonized Liposomes and PGE1 Rescue Animals from Endotoxemia When Given After Endotoxin Challenge. The extraordinary protection afforded to rats by PGE1 plus liposomes led us to further assess this treatment modality. We therefore induced endotoxemia and administered single bolus intravenous injections of PGE1 plus liposomes at various times after challenge. The results (Fig. 6 ) indicate that rescue of animals from lethal endotoxic shock can be achieved even when treatment is withheld for significant periods of times after endotoxin challenge. While some mortality occurred prior to treatment, all rats alive at up to 8 hr after challenge survived. Even rats treated up to 16 hr after challenge showed a significant increase in survival as compared with controls. We are unaware of any experimental or clinical data other than these that suggest successful intervention is possible in the later stages of the systemic inflammatory response (29) . Current effective experimental treatment modalities for sepsis require either prophylactic treatment (30, 31) or administration at the time of endotoxin challenge (32) (33) (34) . Unlike these sepsis therapies, treatment with PGE1 plus liposomes takes advantage of the activation of professional phagocytes and thus exploits the natural cellular immune response to septic insult. Regardless of the actual target cells or mechanisms, our data indicate a clinical potential for PGE1 and liposomes in ameliorating sepsis and other inflammatory diseases.
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